Omega-3 fatty acids, atherogenesis, and endothelial activation

Journal of Cardiovascular Medicine

Volumn 8, Issue SUPPL. 1, 2007, Pages

  De Caterina, Raffaele ^a,b   Zampolli, Antonella ^b,c  

^a UNIVERSITY OF CHIETI   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Endothelium; Fish oils; n 3 polyunsaturated fatty acids; Omega 3 fatty acids

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; DIETARY INTAKE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; HEART INFARCTION; HEART INFARCTION PREVENTION; HUMAN; NONHUMAN; PRIMARY PREVENTION; RESTENOSIS; SECONDARY PREVENTION; SUDDEN DEATH; THERAPY EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSTABLE ANGINA PECTORIS;

ANIMALS; CORONARY ARTERY DISEASE; CYTOKINES; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; HUMANS; LIPIDS;

EID: 34548731950     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000289267.13353.5a     Document Type: Conference Paper

References (31)

1. Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003; 23:151-152.
2. Middaugh JP. Cardiovascular deaths among Alaskan Natives, 1980-86. Am J Public Health 1990; 80:282-285.
3. Newman WP, Middaugh JP, Propst MT, Rogers DR. Atherosclerosis in Alaska Natives and non-natives. Lancet 1993; 341:1056-1057.
4. Erkkila AT, Lichtenstein AH, Mozaffarian D, Herrington DM. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 2004; 80:626-632.
5. Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 1995; 25:1492-1498.
6. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 130:554-562.
7. Angerer P, Kothny W, Stork S, von Schacky C. Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. Cardiovasc Res 2002; 54:183-190.
8. Angerer P, von Schacky C. n-3 Polyunsaturated fatty acids and the cardiovascular system. Curr Opin Lipidol 2000; 11:57-63.
9. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996; 77:31-36.
10. Maresta A, Balduccelli M, Varani E, Marzilli M, Galli C, Heiman F, et al. Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis ITalian Study (ESPRIT). Am Heart J 2002; 143:E5.
11. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review. Atherosclerosis 2006; 184:237-246.
12. Yokoyama M, Origasa H, on behalf of the JELIS Investigators. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). Am Heart J 2003; 146:613-620.
13. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishihawa Y, et al., on behalf of the Japan EPA Lipid Intervention Study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients: a randomised open-label, blinded endpoint analysis. Lancet 2007; 369:1090-1098.
14. De Caterina R, Zampolli A. Antiatherogenic effects of omega-3 fatty acids - evidence and mechanisms. Heart International (in press).
15. Harris WS. n-3 Fatty acids and serum lipoproteins: animal studies. Am J Clin Nutr 1997; 65 (Suppl):1611S-1616S.
16. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988; 318:549-557.
17. Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65 (Suppl):1645S-1654S.
18. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320:265-271.
19. Fox PL, DiCorleto PE. Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 1988; 241:453-456.
20. Kaminski WE, Jendraschak E, Kiefl R, von Schacky C. Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 1993; 81:1871-1879.
21. Hansen JB, Olsen JO, Wilsgard L, Osterud B. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J Intern Med Suppl 1989; 731:133-139.
22. Shimokawa H, Vanhoutte PM. Dietary omega 3 fatty acids and endothelium-dependent relaxations in porcine coronary arteries. Am J Physiol 1989; 256 (Pt 2):H968-H973.
23. Baumann KH, Hessel F, Larass I, Muller T, Angerer P, Kiefl R, et al. Dietary omega-3, omega-6, and omega-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. A randomized volunteer study. Arterioscler Thromb Vasc Biol 1999; 19:59-66.
24. De Caterina R, Massaro M. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol 2005; 206:103-116.
25. De Caterina R, Cybulsky MA, Clinton SK, Gimbrone MA, Libby P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot Essent Fatty Acids 1995; 52:191-195.
26. Weber C, Erl W, Pietsch A, Danesch U, Weber PC. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 1995; 15:622-628.
27. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest 1993; 68:499-508.
28. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995; 9:899-909.
29. De Caterina R, Bernini W, Carluccio MA, Liao JK, Libby P. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res 1998; 39:1062-1070.
30. Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, et al. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A 2006; 103:15184-15189.
31. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978; 2:117-119.